BIOCRYST PHARMACEUTICALS's ticker is and the CUSIP is 09058V953. A total of 4 filers reported holding BIOCRYST PHARMACEUTICALS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,216,040 | +65.4% | 313,000 | +64.5% | 0.00% | – |
| Q2 2023 | $1,339,712 | -57.8% | 190,300 | -50.0% | 0.00% | -100.0% |
| Q1 2023 | $3,172,536 | -33.0% | 380,400 | -7.7% | 0.00% | -50.0% |
| Q4 2022 | $4,733,204 | +29.7% | 412,300 | +42.3% | 0.00% | 0.0% |
| Q3 2022 | $3,650,000 | +3.3% | 289,700 | -13.3% | 0.00% | +100.0% |
| Q2 2022 | $3,535,000 | – | 334,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 332,500 | $2,477,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,011 | $1,498,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |